References
Ovarian ablation in early breast cancer: overview of the randomized trials. Early Breast Cancer Trialists’ Collaborative Group [no authors listed]. Lancet 1996, 348:1189–1196.
Hiraga T, Williams PJ, Ueda A, et al.: Zoledronic acid inhibits visceral metastases in the 4 T1/luc mouse breast cancer model. Clin Cancer Res 2004, 10:4559–4567.
Aft R, Watson M, Ylagan L, et al.: Effect of zoledronic acid on bone marrow micrometastases in women undergoing neoadjuvant chemotherapy for breast cancer [abstract 1021]. J Clin Oncol 2008, 26(15 Suppl):46S.
Diel IJ, Solomayer EF, Costa SD, et al.: Reduction in new metastases in breast cancer with adjuvant clodronate treatment. N Engl J Med 1998, 339:357–363.
Disclosure
Dr. Larry J. Suva has given expert testimony on behalf of Novartis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Suva, L.J. Adjuvant Bisphosphonates in Breast Cancer: The ABCSG-12 Study. Curr Osteoporos Rep 8, 57–59 (2010). https://doi.org/10.1007/s11914-010-0012-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11914-010-0012-5